# Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension

> **NCT01111890** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 70 (actual)

## Conditions studied

- Glaucoma
- Ocular Hypertension

## Interventions

- **DRUG:** Azarga (brinzolamide 1% / timolol 0.5%)
- **DRUG:** Cosopt (dorzolamide 2% / timolol 0.5%)

## Key facts

- **NCT ID:** NCT01111890
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01111890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01111890, "Comparison of the Efficacy of AZARGA® Versus COSOPT® in Patients With Open-Angled Glaucoma or Ocular Hypertension". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT01111890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*